baber/WOPTO huggingface dataset:
Patent NZ-564123-A (NZ)
Title: Process for production of a nitrogen containing epihalohydrin polymer
Inventor: STRUCK OLIVER
IPC: B01D11/02
Filed: 2006-06-09
Abstract: Disclosed is a process for the production of a nitrogen containing epihalohydrin polymer involving reaction of a nitrogen-containing precursor selected from the group consisting of amines, poly-amines, polyaminoamides, polyurethanes and mixtures thereof with epihalohydrin to form of a solution of said epihalohydrin polymer, the process comprising a purification step to remove organic impurities from the formed solution of the epihalohydrin polymer, said purification step comprising contacting the solution of the epihalohydrin polymer with a fluid under liquid, supercritical or near supercritical conditions to effect extraction of organic impurities from the solution of the epihalohydrin polymer to the fluid, withdrawing fluid enriched in organic impurities from the solution of the epihalohydrin polymer, and separating extracted impurities from the withdrawn fluid, wherein the fluid comprises a substance that at atmospheric pressure and room temperature (about 25 degrees C) is gaseous. Also disclosed is a process for purifying a solution of a nitrogen containing epihalohydrin polymer formed by reaction of a nitrogen-containing precursor selected from the group consisting of amines, poly-amines, polyaminoamides, polyurethanes and mixtures thereof with epihalohydrin comprising the steps of contacting the solution of the epihalohydrin polymer with a fluid under liquid, supercritical or near supercritical conditions to effect extraction of organic impurities from the solution of the epihalohydrin polymer to the fluid, withdrawing fluid enriched in organic impurities from the solution of the epihalohydrin polymer, and separating extracted impurities from the withdrawn fluid, wherein the fluid comprises a substance that at atmospheric pressure and room temperature (about 25 degrees C) is gaseous.
Patent NZ-565625-A (NZ)
Title: Roofing capping tiles held between header tiles by locating and fixing to flanges outwardly directed from header tiles
Inventor: SHUBIN JEREMIAH
Filed: 2008-01-31
Abstract: Provided is a method for capping a ridge line of a tiled roof with one or more ridge cap tiles. The method includes positioning first and second flanges on first and second courses of header tiles respectively such that each flange extends outwardly from its respective course of header tiles. One or more ridge cap tiles are fitted over said ridge line and between said first and second flanges such that each flange is adjacent a respective side of the ridge cap tiles and the cap if fixed to the flanges typically with the flanges being perforated and using settable substances to fix. A ridge capping system is also provided.
Patent NZ-567656-A (NZ)
Title: Methods of filtering a liquid stream produced from an in situ heat treatment process
Inventor: DEN BOESTERT JOHANNES LEENDERT WILLEM CORNELIS
IPC: E21B43/24
Filed: 2006-10-20
Abstract: Disclosed is a method for producing a hydrocarbon product, comprising: providing at least a portion of a liquid stream to a feed side of a membrane of a nanofiltration system to produce a permeate, and a retentate that comprises clogging compositions wherein: a formation fluid comprising mobilized fluids, visbroken fluids, pyrolyzed fluids, or mixtures thereof obtained by an in situ heat treatment process is separated to produce a gas stream and the liquid stream; the permeate is processed in one or more processing units downstream of the nanofiltration system to form one or more crude products; at least one of the processing units comprises a hydrotreating unit; and contacting the permeate with one or more catalysts in the presence of hydrogen to produce a product suitable for transportation and/or refinery use. Further disclosed is a hydrocarbon product when produced by the above method.
Patent NZ-570623-A (NZ)
Title: A method for optimising the security value of an investment portfolio
Inventor: PEARSE ANDREW
IPC: G06Q40/00
Filed: 2007-02-09
Abstract: An automated method of optimising a security value of an investment portfolio financed using a margin loan facility and a system for automatically optimising a security value of an investor investment portfolio financed using a margin loan facility are disclosed. The investment portfolio includes a plurality of security holdings at least some of which comprise a diversified portion of the portfolio. The system comprises (1) a server, and (2) one or more user terminals located in or more user locations. The server determines a market value and composition of the portfolio based on a level of diversification in the portfolio. The composition of the portfolio includes a diversified portion and a standard portion. The server further generates a maximum security value based on: (i) a first loan value generated based on a diversified loan-to-value ratio (LVR) and the diversified portion of the portfolio, and (ii) a second loan value generated based on a standard LVR and the standard portion of the portfolio, and determines whether the margin loan requires clearing based on a comparison of the maximum security value against a minimum security value required to secure the margin loan.
Patent NZ-571942-A (NZ)
Title: Structural member of generally circular cross section with flattened portion
Inventor: BARRETT JOHN FABIAN
IPC: E04C3/02
Filed: 2008-10-13
Abstract: Structural members, processes for forming the structural members, and methods of using the members for repairing a bridge are disclosed. The member (10) is a hollow section with a generally circular cross section having one or two flat regions (14). The members may be used replace ageing timber girders in a bridge under repair.
Patent NZ-573215-A (NZ)
Title: A disc tumbler cylinder lock and key combination wherein the lock comprises stack of tumblers
Inventor: MARTIKAINEN KAARLO
IPC: E05B19/02
Filed: 2007-06-11
Abstract: A disc tumbler cylinder lock and key (1) combination is disclosed. The lock comprises a cylinder body (9) and within it an inner cylinder (11). The inner cylinder (11) contains a stack of tumblers (25) that comprises tumblers (25) to be turned with a key (1). At least one of the tumblers is an O-tumbler. The tumblers (25) comprises a key channel and an edge groove (27) at the its outer edge. The cylindrical lock comprises a detent pin (12) for locking the lock. The detent pin (12) is able to be arranged into the edge grooves (27) of the tumblers (25) by turning the tumblers with the key (1) to the of the detent pin (12) for opening the lock. The shank (2) of the key comprises an outer surface (2A) and at least one combination area (4). The shank also comprises at least one groove (6) with a bottom section (6A) and side sections. The side sections are transverse to the bottom section (6A) between the bottom section (6A) and the outer surface (2A) of the shank (2). The bottom section (6A) of the groove (6) is the main driving surface through which a force turning the key is transferable to the inner cylinder of the disc tumbler cylindrical lock. The stack of tumblers (25) also comprises a transmission disc (10) that comprises a key channel (14), an edge groove (13) and a transmission element (19). The edge (15) of the key channel (14) comprises a mating surface (21) for the main driving surface (6A) of the key. The inner cylinder (11) comprises a movement area (23) for the transmission element (19), and the mating surfaces (22) to transmit the force turning the transmission disc (10) to the inner cylinder (11). The edge groove (13) of the transmission disc (10) is able to be set at the position of the detent pin (12) and the transmission element (19) is able to set against the mating surfaces (22) when turning the key (1) for opening the lock.
Patent NZ-575520-A (NZ)
Title: New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds
Inventor: STENKAMP DIRK
IPC: C07D403/14
Filed: 2007-08-20
Abstract: Disclosed are pyridine derivatives represented by general formula (I) or salts, tautomers, diastereomers and enantiomers thereof. Examples of the compounds of formula (I) include 4-benzyloxy-1-[2-oxo-2-(4-pyrrolidin-1-ylmethyl-phenyl)-ethyl]-1H-pyridin-2-one, 4-(5-bromo-pyridin-2-ylmethoxy)-1-[2-oxo-2-(1,2,3,4-tetrahydro-isoquinolin-7-yl)-ethyl]-1H-pyridin-2-one and 4-(4-fluoro-benyloxy)-1-(2-[4-(4-hydroxy-piperidin-1-ylmethyl)-phenyl]-2-oxo-ethyl]-1H-pyridin-2-one. Also disclosed is the use of the compounds of formula (I) for treating metabolic disorders or eating disorders.
Patent NZ-576705-A (NZ)
Title: IKK-Beta SERINE-THREONINE PROTEIN KINASE INHIBITORS
Inventor: MOFFAT DAVID FESTUS CHARLES
IPC: A61K31/381
Filed: 2007-10-29
Abstract: Disclosed is a compound of formula (IA) or (IB), or a salt, N-oxide, hydrate or solvate thereof e.g. Cyclopentyl N-{ 4-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]benzyl} -L-leucinate, wherein R7 and Z are defined in the specification for the treatment of rheumatoid arthritis, psoriasis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, chronic obstructive pulmonary disease, asthma, multiple sclerosis, diabetes, atopic dermatitis, graft versus host disease, or systemic lupus erythematosus.
Patent NZ-577197-A (NZ)
Title: Pyrimidine compounds especially 4-phenylamino-2-arylamino-pyrimidine derivatives and compositions as protein kinase inhibitors
Inventor: MICHELLYS PIERRE-YVES
IPC: C07D213/74
Filed: 2007-11-20
Abstract: Disclosed is are 4-phenylamino-2-arylamino-pyrimidine compounds of formula 2 where either R8 or R9 includes a pyrrolidinyl, piperidinyl or azetidinyl group which is attached to the phenyl ring via a carbon atom. The rest of the substituents are as described in the specification. Also disclosed is a pharmaceutical composition containing a compound of formula 2; a combination containing a compound of formula 2 and a chemotherapeutic agent and the use of a compound of formula 2 for producing a medicament for treating a condition mediated by anaplastic lymphoma kinase, and optionally the medicament is formulated for combination with a second therapeutic agent, wherein said condition is an autoimmune disease, a transplantation disease, an infectious disease, a cell proliferative disorder; and optionally the medicament is formulated for combination with a second therapeutic agent, wherein said cell proliferative disorder is lymphoma, osteosarcoma, melanoma, non-small cell lung carcinoma, neuroblastoma or a tumour selected from breast, renal, prostate, colorectal, thyroid, ovarian, pancreatic, neuronal, lung, uterine and gastrointestinal tumour.
Patent NZ-586069-A (NZ)
Title: Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
Inventor: WANG XIAODONG
IPC: C07D487/14
Filed: 2008-12-18
Abstract: Disclosed herein are fused pyridine, pyrimidine compounds of formula I or II, wherein the substituents are as defined within the specification, processes for its preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as selective inhibitors of cyclin dependent kinase Cdk4, wherein CdK6 is also structurally and functional similar to Cdk4 and there is useful for treating cancer and for reducing tumour size in a subject.
Patent NZ-588631-A (NZ)
Title: Disc brake calliper support
Inventor: JAMES ALLAN MARTIN
IPC: F16D55/22
Filed: 2009-04-17
Abstract: 588631 A disc brake calliper support is disclosed. The support includes a calliper mounting for coupling the support relative to a disc brake calliper, an anchor mounting for anchoring the support relative to an axis about which the disc rotates, and a support structure between the calliper mounting and the anchor mounting. The support structure is adapted to support the calliper relative to the axis against deflection out of a plane of the disc during application of the brake. The support structure still allows linear movement between the calliper mounting and the anchor mounting to facilitate operation of the disc brake.
Patent NZ-589191-A (NZ)
Title: Quinazoline derivatives that inhibit the activity of egfr
Inventor: ZHANG WEIHAN
IPC: A61K31/517
Filed: 2009-06-30
Abstract: 589191 Provided is a quinazoline compound of formula 1 as depicted, with defined substituents. The compound inhibits the activity of the EGFR and can be used to treat cancer.
Patent NZ-592528-A (NZ)
Title: Improved dissolution stability of calcium carbonate tablets
Inventor: OLSEN PEDER MOHR
IPC: A61K9/20
Filed: 2009-11-17
Abstract: 592528 Disclosed herein is a method for the preparation of a tablet comprising at least 50% w/w of calcium carbonate, the method comprising: providing a particulate composition comprising a) calcium carbonate, b) a binding sugar alcohol selected from sorbitol or isomalt, or combinations thereof c) a 5 non-binding sugar alcohol selected from mannitol, maltitol or xylitol, or combinations thereof and d) one or more pharmaceutically acceptable excipients, which is not magnesium stearate, calcium stearate or stearic acid; and compressing said composition using a tabletting machine equipped with at least one pair of punches and dies, wherein the pair of punches and die before filling 10 the die with said particulate composition is sprayed with a composition comprising a lubricant selected from magnesium stearate, calcium stearate or stearic acid or combinations thereof. Additionally disclosed are calcium carbonate tablets, for example a tablet containing: 70-75% w/w of calcium carbonate, 4-25% w/w of one or more binding sugar alcohols selected from sorbitol or isomalt or combinations thereof, 4-25% w/w of one or more non-binding sugar alcohols selected from mannitol, maltitol or xylitol, or combinations thereof, 2-10% w/w of one or more pharmaceutically acceptable excipients, wherein said excipients are not lubricants including magnesium stearate, calcium stearate, or stearic acid, 0-2% w/w of one or more flavours and/or artificial sweeteners, 0.001-0.01% w/w of magnesium stearate, calcium stearate or stearic acid with the proviso that the total amount corresponds to 100% w/w, and wherein the content of magnesium stearate, calcium stearate or stearic acid solely is present on the outermost (external) surface of the tablet.
Patent NZ-592996-A (NZ)
Title: Salts of isobutyric acid (1 r*, 2r*, 4r* ) -2- (2-{ [3- (4, 7-dimeth0xy-1 h-benzoimidazol-2-yl) -propyl] -methyl-amino } -ethyl) -5-phenyl-bicyclo [2.2.2] oct-5- en- 2 -yl ester
Inventor: ABELE STEFAN
IPC: A61P9/00
Filed: 2009-10-21
Abstract: Disclosed herein is a crystalline salt of the compound isobutyric acid (1R*,2R*,4R*)-2-(2-{ [3-(4,7-dimethoxy-1H-benzoimidazol-2-yl)-propyl]-methyl-amino} -ethyl)-5-phenylbicyclo[2.2.2]oct-5-en-2-yl ester; wherein said crystalline salt consists of: 1 equivalent of isobutyric acid (1R*,2R*,4R*)-2-(2-{ [5 3-(4,7-dimethoxy-1Hbenzoimidazol-2-yl)-propyl]-methyl-amino} -ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester; an acid component consisting of 1 to 2 equivalents of an acid selected from the group consisting of hydrobromic acid, sulfuric acid, maleic acid, fumaric acid, methanesulfonic acid, para-toluenesulfonic acid, benzenesulfonic acid, naphthalene-1,5-disulfonic acid, naphthalene-2-sulfonic acid, and ethanesulfonic acid; and 0 to 5 equivalents of water. Said crystalline salt is useful in the treatment or prevention of chronic stable angina, hypertension, ischemia (renal and cardiac), cardiac arrhythmias including atrial fibrillation, cardiac hypertrophy, or congestive heart failure.
Patent NZ-595516-A (NZ)
Title: Apparatus for manufacturing an absorbent article wherein a sheet, comprising an absorbent core, is folded into three parts
Inventor: HAMADA AKIRA
IPC: A61F13/49
Filed: 2010-03-29
Abstract: A device for producing an absorbent article, which comprises an absorbent core and a sheet carrying the absorbent core thereon, comprising a transportation part which conveys the sheet that carries the absorbent core thereon in the transportation direction, and a bending part which bends the sheet in a cross-machine direction while the conveying part conveys the sheet. The sheet comprises a first part, which is located at a bending position where the bending part bends the sheet in the cross-machine direction, being apart from the absorbent core in the cross-machine direction. The bending part bends the sheet in such a manner that, in the sheet, a second part, which is located farther from the absorbent core than the first part in the cross-machine direction, falls onto a third part, which is located closer to the absorbent core than the first part in the cross-machine direction and further comprising a restricting part which restricts the access of the first part to the absorbent core in the cross-machine direction, when the bending part bends the sheet.
Patent NZ-595745-A (NZ)
Title: Method for obtaining cellulose from biomass comprising lignocellulose
Inventor: PATT RUDOFF
IPC: D21C3/20
Filed: 2010-02-25
Abstract: 595745 Disclosed is a method for obtaining pulp by removal of lignin from a lignocellulosic biomass in the form of plants and/or plant parts, the lignocellulosic biomass being digested in a digester in an alkaline medium comprising alkanolamine having 1 to 8 carbon atoms, and dissolved lignin being removed from the resulting raw pulp, characterized in that the lignocellulosic biomass does not originate from wood and is digested at a temperature of less than about 170°C in a digestion medium based on alkanolamine and water, in which the weight ratio of alkanolamine to water is adjusted to 70:30 to 20:80, and raw pulp produced is separated from the waste liquor by customary methods. Also disclosed is the use of a product obtained by the method.
Patent NZ-597107-A (NZ)
Title: Heterocyclic compounds for the treatment of neurological and psychological disorders
Inventor: ZEIDAN TAREK A
IPC: A61K31/497
Filed: 2010-06-24
Abstract: 597107 Disclosed herein are lactam compounds of Formula I, wherein the variables are defined in the specification, and their use for the treatment of neurological and psychiatric disorders including schizophrenia, bipolar disorder, anxiety disorder and insomnia. Embodiments of the compounds include the following: (7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-5-dihydroquinolin-1(2H)-yl)methyl 2-(2-(2-methoxyethoxy)ethoxy)acetate, (7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinolin-1(2H)-yl)methyl 4-acetamidobutanoate, and (5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloro-2-oxoindolin-1-yl)methyl palmitate.
Patent NZ-598094-A (NZ)
Title: Solid mineral composition, method for preparing same and use thereof for reducing heavy metals in flue gas
Inventor: BRASSEUR ALAIN
IPC: B01D53/64
Filed: 2010-07-13
Abstract: Disclosed herein is solid composition comprising a mineral compound, doped with a halide salt, wherein the surface accessible to flue gases is partly or completely covered with a halide salt, said mineral compound being selected from the group consisting of halloysite, calcium or magnesium carbonates or hydroxides, and sodium carbonates as well as of mixtures thereof.
Patent NZ-598789-A (NZ)
Title: Heavy metal remediation system
Inventor: RUIZ OSCAR
IPC: C02F3/34
Filed: 2010-08-20
Abstract: Patent No. 598789 Disclosed is a bacterium comprising at least one transgenic chelator agent from among a mammalian metallothionein (mt) gene, a beta-galactosidase (beta-gal) gene, or a polyphosphate kinase (ppk) gene, wherein the expressed chelator agent is not a fusion protein, wherein the bacterium is not engineered for co-expression of mer genes, and wherein the bacterium is resistant to at least one heavy metal, wherein when the heavy metal is mercury, the bacterium resists between at least 20 muM and about 100 muM mercury.
Patent NZ-599126-A (NZ)
Title: In-bed solids control valve
Inventor: MARYAMCHIK MIKHAIL
IPC: B01J8/18
Filed: 2010-09-29
Abstract: 599084 Disclosed is a circulating fluidized bed (CFB) boiler with a CFB reaction chamber having side walls and a grid defining a floor at a lower end of the CFB reaction chamber. The boiler has a bubbling fluidized bed (BFB) located within a lower portion of the CFB reaction chamber. The BFB is bound by outer wall(s) of the CFB reaction chamber, the floor of the CFB reaction chamber and enclosure wall(s) formed by cooled tubes that extend upward from the floor of the CFB to the height of the BFB. The boiler has a controllable in-bed heat exchanger (IBHX) which has a heating surface and occupies part of part of the CFB reaction chamber floor. The INHX is surrounded by the enclosure walls of the BFB. The boiler has an in-furnace secondary air nozzle formed by the cooled tubes of the BFB enclosure wall that are formed into at least one group that extends from the top of the BFB enclosure wall across the width of the BFB until reaching the outer wall of the CFB.
Patent NZ-600267-A (NZ)
Title: Combined oral preparation of theobromine and a decongestant for cough therapy
Inventor: BREW JOHN
IPC: A61K31/4402
Filed: 2010-12-14
Abstract: ABSTRACT - 600267 The disclosure relates to an agent consisting of theobromine and an antihistamine as a combined preparation for use in a therapy of cough, wherein the agent is manufactured for administration by an oral route, wherein the antihistamine is selected from diphenhydramine, loratadine, desloratadine, alimemazine, dimenhydrinate, doxylamine, meclizine, quetiapine, fexofenadine, pheniramine, cetirizine, promethazine, clemastine, chlorpheniramine, dexchlorpheniramine, levocetirizine, hydroxyzine, alimemazine, acrivastine, cyproheptadine, astemizole, fexofenadine, loratadine, cetirizine, levocetirizine, brompheniramine, dextrobrompheniramine, promethazine, mizolastine, and triprolidine, and wherein the antihistamine, preferably chlorpheniramine, is to be administered in a dose of 0.1 to 30 mg/kg/day.
Patent NZ-603430-A (NZ)
Title: Aquaculture assembly and method
Inventor: LESLIE STEVEN J
IPC: A01K61/00
Filed: 2011-04-07
Abstract: Artificial intertidal or sub tidal aquaculture. An aquaculture assembly for culturing oysters in deep waters includes at least one structure for supporting and growing the oysters, floatation for the structure and an anchor to anchor the float to the sea bed. The floatation may be incorporated into the structure for supporting the growing oysters. By suitable selection of the anchoring and floatation arrangement the support structure is held: (a) above the water surface at low-tide, and at least substantially below the water surface at high-tide to maintain the oysters under artificial intertidal conditions, or, (b) just below the water surface at low-tide, and fully below the water surface at high-tide to maintain the oysters under artificial sub-tidal conditions. The species considered for culturing using assemblies and methods of the present invention comprise bivalve molluscs such as oysters, oyster spat, mussel spat (which benefit from some time spent in an inter-tidal/sub-tidal zone), clams, cockles, abalone, and conch. According to a further particular embodiment, the species considered for culturing using systems and methods of the present invention comprise inter-tidal bivalve molluscs and, in yet a further embodiment, oysters, in particular oysters of the genus Crassostrea or Saccostrea (such as Pacific or Sydney rock oysters). Sub-tidal species such as the Australian native flat oyster (Ostrea angasi) and European flat oyster (Ostrea edulis) benefit from being locked in the sub-tidal zone just sub-surface, where they gain the benefit of the scouring action of the waves, which will help clean and harden their shells, while they experience the full range of depths in the artificial sub-tidal zone.